<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03922165</url>
  </required_header>
  <id_info>
    <org_study_id>18-015848</org_study_id>
    <nct_id>NCT03922165</nct_id>
  </id_info>
  <brief_title>Healthy Sleep for Children With Down Syndrome</brief_title>
  <acronym>HELP-DS</acronym>
  <official_title>Healthy Sleep for Children With Down Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of The King's Daughters</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multi-center observational study (utilizing the sites enrolling patients
      for the Pediatric Adenotonsillectomy Trial for Snoring (PATS) [1U011HL125307-O1A1]) is to
      gather data regarding children with Down syndrome (DS) and Sleep Disordered Breathing (SDB)
      referred for treatment with adenotonsillectomy to inform a future randomized controlled trial
      in this population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Down syndrome (DS) is associated with a wide range of neurobehavioral and physical
      morbidities. Obstructive sleep apnea (OSA) is prevalent in children with DS and causes a
      myriad of physiological stresses that may exacerbate neurobehavioral and cardiac morbidities.
      Improving sleep health thus provides a modifiable intervention target for improving behavior,
      cognition, quality of life, and physical health of children with DS. However, critical
      knowledge gaps limit the adoption and implementation of effective OSA interventions,
      resulting in practice variability and suboptimal treatment of OSA across the spectrum of DS.
      In particular, it is in unclear how to select candidates likely to benefit from
      adenotonsillectomy (AT) and how to utilize information from polysomnographic, clinical, and
      demographic parameters to predict children most likely to benefit from AT compared to
      alternative treatments or to watchful waiting. The goal of this study is to collect the
      necessary data to plan and execute a future pivotal RCT of the role of OSA treatment in the
      care of children with DS. This study will provide critical information on the methodological
      approaches for conducting such a randomized controlled clinical trial (RCT), informing the
      appropriate recruitment strategies, patient population and outcome measures for a future
      clinical trial. The investigators will leverage expertise in pediatric sleep medicine,
      clinical trials, neuropsychology, and DS as well as the PATS clinical trials infrastructure
      to catalyze a new DS clinical research initiative. Our proposed next steps are to enroll in
      an observational study at active PATS centers 50 children with DS who are referred for
      clinically indicated evaluation and treatment of OSA. At baseline and 6 months following AT,
      these children will undergo systematic assessments of sleep, behavior, cognition, daytime
      functioning, and quality of life, generating key data to inform the design of a later pivotal
      RCT.

      Healthy Sleep for Children with Down Syndrome (HELP-DS) intends to take advantage of a
      successful collaboration of leaders in sleep medicine, otolaryngology and clinical trials to
      efficiently leverage experiences from the The Childhood Adenotonsillectomy Trial (CHAT) as
      well as the current resources of the PATS trial to collect data for the evaluation of key
      questions needed to design a future RCT, including approaches related to the selection of
      participating sites, the patient population to receive the intervention, and outcome
      measurements.

      The primary objective of HELP-DS to determine the feasibility of recruiting and retaining
      individuals in an observational study of AT across multiple clinical sites.

      Secondary objectives are:

        1. Evaluate the feasibility of collecting a range of baseline and outcome data, and
           specifically the ability of children to perform neurobehavioral assessments (GoNoGo,
           pegboard task).

        2. Understand issues related to patient preference, equipoise, and barriers to treatment.
           The investigators will track how many children referred for AT actually undergo surgery,
           the time interval between referral and surgery, other interventions pursued, and factors
           such as insurance, socio-economic factors, and cultural norms, that associate with
           family-decision making.

        3. Examine the consistency and completeness of Healthcare Utilization (HCU) data extracted
           across our sites, describing differences by recruitment site, health, system
           characteristics, insurance-related factors, etc. The investigators will estimate
           incidence rates of HCU events for hospital admissions, emergency department/unscheduled
           office visits, specialty consultations and medication use during the 6 months following
           surgery and compare rates to those for the year prior to surgery.

      These aims have substantial public health significance given the high morbidity of Down
      syndrome and sleep-disordered breathing in children.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>% enrolled/approached</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of families approached for participation that sign informed consent to participate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>% retained/enrolled</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of consented families that completed study participation.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Down Syndrome</condition>
  <condition>Sleep Disordered Breathing</condition>
  <arm_group>
    <arm_group_label>DS peds eligible for Adenotonsillectomy</arm_group_label>
    <description>Dyads of caregivers and children with DS aged 3-13 years diagnosed with SDB and referred for treatment with adenotonsillectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adenotonsillectomy</intervention_name>
    <description>Routine AT per clinical care.</description>
    <arm_group_label>DS peds eligible for Adenotonsillectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Dyads of caregivers and children with DS aged 3-13 years diagnosed with SDB and referred
        for treatment with adenotonsillectomy (AT) will be recruited.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DS diagnosis regardless of genetic status (e.g., mosaicism or translocation).

          -  Aged &gt;3 to &lt;13 years at the date of consent.

          -  Primary indication for AT is nocturnal obstructive symptoms (i.e., not recurrent
             infections or other indications).

          -  Deemed to be a candidate for AT by Ear, Nose and Throat (ENT) evaluation; that is, no
             technical issues that would be a contraindication for surgery such as submucous cleft
             palate.

        Exclusion Criteria:

          -  Prior tonsillectomy (partial or complete).

          -  Severe chronic health conditions that would contradict surgery (severe morbid obesity,
             unrepaired cyanotic congenital heart disease, bleeding disorders).

          -  Severe behavioral problems that would preclude participation in the study's testing
             procedures (PSG, actigraphy).

          -  Severe OSA with respiratory failure needing urgent/emergent management

          -  Plan to undergo additional airway surgery at the time of AT.

          -  Caregiver/child planning to move out of the area within 6 months.

          -  Caregiver/child does not speak English or Spanish well enough to complete the
             behavioral and performance measures.

          -  Child in foster care.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan S Redline, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rui Wang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan L Furth, Md, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael G Morrical</last_name>
    <phone>8573070332</phone>
    <email>mmorrical@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessie P Bakker, PhD</last_name>
    <phone>6177325987</phone>
    <email>jpbakker@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Libby Hobson</last_name>
      <phone>734-936-4817</phone>
      <email>mehobson@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Ronald D Chervin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fauziya Hassan, MBBS, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan L Garetz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David A Zopf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suzanna Hicks</last_name>
      <phone>513-636-4944</phone>
      <email>suzanna.hicks@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Raouf S Amin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stacey L Ishman, MD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals-Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heather Rogers</last_name>
      <phone>216-368-0475</phone>
      <email>heather.rogers@uhhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Carol L Rosen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kristie R Ross, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hudson G Taylor, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jay Shah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Rosenthal</last_name>
      <phone>215-590-9184</phone>
      <email>karamessil@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Ignacio E Tapia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jerilynn Radcliffe, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisa M Elden, MD MS FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lauren Plummer</last_name>
      <phone>214-456-2269</phone>
      <email>Lauren.Plummer@childrens.com</email>
    </contact>
    <investigator>
      <last_name>Ronald B Mitchell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kamal M Naqvi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of the King's Daughters</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Stone</last_name>
      <phone>757-388-6238</phone>
      <email>stonelj@evms.edu</email>
    </contact>
    <investigator>
      <last_name>Christina M Baldassari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael J Strunc, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer L Wiebke, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://helpds.study/</url>
    <description>HELP-DS study portal</description>
  </link>
  <reference>
    <citation>Mai CT, Kucik JE, Isenburg J, Feldkamp ML, Marengo LK, Bugenske EM, Thorpe PG, Jackson JM, Correa A, Rickard R, Alverson CJ, Kirby RS; National Birth Defects Prevention Network. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol. 2013 Nov;97(11):709-25. doi: 10.1002/bdra.23198.</citation>
    <PMID>24265125</PMID>
  </reference>
  <reference>
    <citation>Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL, McCabe ER. Current estimate of Down Syndrome population prevalence in the United States. J Pediatr. 2013 Oct;163(4):1163-8. doi: 10.1016/j.jpeds.2013.06.013. Epub 2013 Jul 23.</citation>
    <PMID>23885965</PMID>
  </reference>
  <reference>
    <citation>Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13(3):221-7. Review.</citation>
    <PMID>17910090</PMID>
  </reference>
  <reference>
    <citation>Bull MJ; Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics. 2011 Aug;128(2):393-406. doi: 10.1542/peds.2011-1605. Epub 2011 Jul 25. Erratum in: Pediatrics. 2011 Dec;128(6):1212.</citation>
    <PMID>21788214</PMID>
  </reference>
  <reference>
    <citation>Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 2002 Mar 23;359(9311):1019-25.</citation>
    <PMID>11937181</PMID>
  </reference>
  <reference>
    <citation>Rajagopal KR, Abbrecht PH, Derderian SS, Pickett C, Hofeldt F, Tellis CJ, Zwillich CW. Obstructive sleep apnea in hypothyroidism. Ann Intern Med. 1984 Oct;101(4):491-4.</citation>
    <PMID>6476635</PMID>
  </reference>
  <reference>
    <citation>Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL. Obstructive sleep apnea in children with Down syndrome. Pediatrics. 1991 Jul;88(1):132-9.</citation>
    <PMID>1829151</PMID>
  </reference>
  <reference>
    <citation>de Miguel-Díez J, Villa-Asensi JR, Alvarez-Sala JL. Prevalence of sleep-disordered breathing in children with Down syndrome: polygraphic findings in 108 children. Sleep. 2003 Dec 15;26(8):1006-9.</citation>
    <PMID>14746382</PMID>
  </reference>
  <reference>
    <citation>Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1527-32.</citation>
    <PMID>10228121</PMID>
  </reference>
  <reference>
    <citation>Edgin JO, Tooley U, Demara B, Nyhuis C, Anand P, Spanò G. Sleep Disturbance and Expressive Language Development in Preschool-Age Children With Down Syndrome. Child Dev. 2015 Nov-Dec;86(6):1984-98. doi: 10.1111/cdev.12443. Epub 2015 Oct 5.</citation>
    <PMID>26435268</PMID>
  </reference>
  <reference>
    <citation>Clausen J, Sersen EA, Lidsky A. Sleep patterns in mental retardation: Down's syndrome. Electroencephalogr Clin Neurophysiol. 1977 Aug;43(2):183-91.</citation>
    <PMID>69529</PMID>
  </reference>
  <reference>
    <citation>Nisbet LC, Phillips NN, Hoban TF, O'Brien LM. Characterization of a sleep architectural phenotype in children with Down syndrome. Sleep Breath. 2015 Sep;19(3):1065-71. doi: 10.1007/s11325-014-1094-6. Epub 2014 Dec 12.</citation>
    <PMID>25500979</PMID>
  </reference>
  <reference>
    <citation>Diomedi M, Curatolo P, Scalise A, Placidi F, Caretto F, Gigli GL. Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects. Brain Dev. 1999 Dec;21(8):548-53.</citation>
    <PMID>10598057</PMID>
  </reference>
  <reference>
    <citation>Reckley LK, Fernandez-Salvador C, Camacho M. The effect of tonsillectomy on obstructive sleep apnea: an overview of systematic reviews. Nat Sci Sleep. 2018 Apr 4;10:105-110. doi: 10.2147/NSS.S127816. eCollection 2018. Review.</citation>
    <PMID>29670412</PMID>
  </reference>
  <reference>
    <citation>Farhood Z, Isley JW, Ong AA, Nguyen SA, Camilon TJ, LaRosa AC, White DR. Adenotonsillectomy outcomes in patients with Down syndrome and obstructive sleep apnea. Laryngoscope. 2017 Jun;127(6):1465-1470. doi: 10.1002/lary.26398. Epub 2017 Jan 5. Review.</citation>
    <PMID>28055122</PMID>
  </reference>
  <reference>
    <citation>Garetz SL, Mitchell RB, Parker PD, Moore RH, Rosen CL, Giordani B, Muzumdar H, Paruthi S, Elden L, Willging P, Beebe DW, Marcus CL, Chervin RD, Redline S. Quality of life and obstructive sleep apnea symptoms after pediatric adenotonsillectomy. Pediatrics. 2015 Feb;135(2):e477-86. doi: 10.1542/peds.2014-0620. Epub 2015 Jan 19.</citation>
    <PMID>25601979</PMID>
  </reference>
  <reference>
    <citation>Franco RA Jr, Rosenfeld RM, Rao M. First place--resident clinical science award 1999. Quality of life for children with obstructive sleep apnea. Otolaryngol Head Neck Surg. 2000 Jul;123(1 Pt 1):9-16.</citation>
    <PMID>10889473</PMID>
  </reference>
  <reference>
    <citation>Chervin RD, Hedger K, Dillon JE, Pituch KJ. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000 Feb 1;1(1):21-32.</citation>
    <PMID>10733617</PMID>
  </reference>
  <reference>
    <citation>Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000 Dec 15;23(8):1043-51.</citation>
    <PMID>11145319</PMID>
  </reference>
  <reference>
    <citation>Arozullah AM, Yarnold PR, Bennett CL, Soltysik RC, Wolf MS, Ferreira RM, Lee SY, Costello S, Shakir A, Denwood C, Bryant FB, Davis T. Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007 Nov;45(11):1026-33.</citation>
    <PMID>18049342</PMID>
  </reference>
  <reference>
    <citation>Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM; American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012 Oct 15;8(5):597-619. doi: 10.5664/jcsm.2172.</citation>
    <PMID>23066376</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>June 21, 2019</last_update_submitted>
  <last_update_submitted_qc>June 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Susan Redline</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Pediatrics</keyword>
  <keyword>Adenotonsillectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

